BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 856 filers reported holding BAXTER INTL INC in Q2 2024. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,337,018 | -28.5% | 69,866 | -8.7% | 0.02% | -30.3% |
Q1 2024 | $3,269,653 | +7.0% | 76,501 | -3.2% | 0.03% | +6.5% |
Q4 2023 | $3,056,498 | +10.7% | 79,061 | +8.1% | 0.03% | +3.3% |
Q3 2023 | $2,760,983 | -16.4% | 73,158 | +0.9% | 0.03% | -11.8% |
Q2 2023 | $3,302,371 | +2.9% | 72,484 | -8.4% | 0.03% | -5.6% |
Q1 2023 | $3,208,580 | -20.3% | 79,107 | +0.1% | 0.04% | -21.7% |
Q4 2022 | $4,027,395 | -5.3% | 79,015 | +0.1% | 0.05% | -9.8% |
Q3 2022 | $4,252,000 | -16.6% | 78,968 | -0.5% | 0.05% | -13.6% |
Q2 2022 | $5,096,000 | +2448.0% | 79,338 | +1200.6% | 0.06% | +210.5% |
Q3 2015 | $200,000 | -53.2% | 6,100 | 0.0% | 0.02% | -60.4% |
Q2 2015 | $427,000 | +2.2% | 6,100 | 0.0% | 0.05% | +2.1% |
Q1 2015 | $418,000 | -6.5% | 6,100 | 0.0% | 0.05% | -11.3% |
Q4 2014 | $447,000 | -7.1% | 6,100 | -9.0% | 0.05% | -32.9% |
Q3 2014 | $481,000 | +48.0% | 6,700 | +48.9% | 0.08% | +43.6% |
Q2 2014 | $325,000 | -1.8% | 4,500 | 0.0% | 0.06% | -21.4% |
Q1 2014 | $331,000 | – | 4,500 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |